Business Wire

SES

12.6.2019 08:57:07 CEST | Business Wire | Press release

Share
SES President and CEO Steve Collar to Chair World Space Week 2020

SES and World Space Week Association jointly announced that SES President and CEO Steve Collar will be Honorary Chair of World Space Week 2020.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190611006082/en/

“I’m excited to chair World Space Week, the biggest space event on Earth, as it focuses global attention on the broad benefits of satellite technology to humankind,” said Collar. “At SES, we always say that we do the extraordinary in space so that our customers can do amazing things on Earth. We believe passionately in the need for content and connectivity everywhere and this belief aligns perfectly with the focus of World Space Week. Space touches the human experience in so many ways and I am proud to help highlight the impact that we, as an industry, have today and will continue to have in the future.”

“We are thrilled that SES’s Steve Collar is using his voice as an industry leader to support World Space Week,” said Dennis Stone, Association President. “Over the course of his career, Steve has demonstrated a steadfast commitment to leveraging the ingenuity of the space industry to positively impact the lives and experiences of people in every corner of the globe. We’re proud to provide him with a platform to shine a light on the important contributions of this exciting field.”

World Space Week is a United Nations-declared event held each year between 4-10 October. In 2018, World Space Week included 5,400 events in 86 nations. In 2019, World Space Week will feature the Moon, with astronomy groups globally focusing telescopes on our nearest neighbor. In 2020, World Space Week will focus on satellite technology and the key role of satellites in today’s world.

Every year, teachers use space during World Space Week to inspire students and a myriad of space events to educate the public about space activities. Collar will encourage the space and satellite industries to participate in World Space Week and will keynote an awards event to recognize top supporters.

Today, nearly 2,000 satellites support crucial functions such as broadcasting, communications and connectivity, navigation, weather forecasting and Earth observations. World Space Week 2020 will also feature new uses of satellites enabled by miniaturization and next-generation systems such as SES’s new O3b mPOWER medium Earth orbit (MEO) system.

About SES

SES is the world’s leading satellite operator with over 70 satellites in two different orbits, Geostationary Orbit (GEO) and Medium Earth Orbit (MEO). It provides a diverse range of customers with global video distribution and data connectivity services through two business units: SES Video and SES Networks. SES Video reaches over 351 million TV homes, through Direct-to-Home (DTH) platforms and cable, terrestrial, and IPTV networks globally. The SES Video portfolio includes MX1, a leading media service provider offering a full suite of innovative services for both linear and digital distribution, and the ASTRA satellite system, which has the largest DTH television reach in Europe. SES Networks provides global managed data services, connecting people in a variety of sectors including telecommunications, maritime, aeronautical, and energy, as well as governments and institutions across the world. The SES Networks portfolio includes GovSat, a 50/50 public-private partnership between SES and the Luxembourg government, and O3b, the only non-geostationary system delivering fibre-like broadband services today. Further information is available at: www.ses.com

About World Space Week and the Association

The largest space event on Earth, UN-declared World Space Week is celebrated October 4-10 annually. The largest space event on Earth, World Space Week consists of a myriad of space-related activities held by space agencies, aerospace industry, schools, planetaria, museums, and astronomy clubs in a common time frame to achieve greater student and public impact through synchronization. In 2018, World Space Week included over 5,400 events in 86 nations. World Space Week Association is the global coordinator of World Space Week. An international non-government, non-profit organization led by volunteers, the Association is a permanent observer on the UN Committee on the Peaceful Uses of Outer Space and is supported by voluntary contributions of sponsors around the world.

Further information is available at: www.worldspaceweek.org

Contact:

Francesca De Florio SES Tel. +352 710 725 500 francesca.deflorio@ses.com

Maruška Strah WSWA Tel. +39 392 517 41 89 mstrah@worldspaceweek.org

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye